Orthopedic Roundup Q4: S&N, Stryker, J&J, Zimmer Biomet See Pandemic-Related Sales Impact
Executive Summary
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
You may also be interested in...
Hospital Staffing Shortages Could Impede Recovery Of Procedure Volumes
Even as COVID-19 hospitalization rates are declining, expected staff shortages could force more hospitals to postpone surgeries and interventions in the coming months.
Zimmer Biomet Receives FDA Nod For Rosa Total Hip System, Intensifying Ortho Robotics Rivalry
Zimmer Biomet adds total hip replacement to its Rosa robotic platform, which will compete against Stryker’s Mako.
Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market
The global market for robotically assisted surgical devices will reach $11.5bn by 2025 as system improvements drive sales.